肺癌中的生物标志物与白细胞介素-2受体
Biomarkers and IL-2R in lung cancer.
作者信息
Marino P, Preatoni A, Fonticoli L, Parodi M, Tarolo G L
机构信息
Dipartimento di Medicina interna, Università, Ospedale S. Paolo, Milano.
出版信息
Recenti Prog Med. 1990 Nov;81(11):702-4.
PMID:1962891
Abstract
A study of TPA, CEA and IL-2R serum levels was conducted in patients untreated with various histological types of bronchial carcinoma. A total of 43 subjects were evaluated. We have observed a significant correlation between serum levels and stage of the disease for both CEA and TPA markers, whereas for IL-2R an increase was shown for the all patients not correlated with stage.
摘要
对未经治疗的各种组织学类型支气管癌患者的血清组织型纤溶酶原激活剂（TPA）、癌胚抗原（CEA）和白细胞介素-2受体（IL-2R）水平进行了研究。共评估了43名受试者。我们观察到CEA和TPA标志物的血清水平与疾病分期之间存在显著相关性，而对于IL-2R，所有患者均显示升高，且与分期无关。
相似文献
1
Biomarkers and IL-2R in lung cancer.肺癌中的生物标志物与白细胞介素-2受体
Recenti Prog Med. 1990 Nov;81(11):702-4.
2
Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.组织学类型和吸烟状态对非小细胞肺癌血清癌胚抗原值解读的影响。
Ann Thorac Surg. 2004 Sep;78(3):1004-9; discussion 1009-10. doi: 10.1016/j.athoracsur.2004.03.019.
3
Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.肺癌患者血清中白细胞介素-18（IL-18）和可溶性白细胞介素-2受体（sIL-2R）的水平
Rocz Akad Med Bialymst. 2004;49:246-51.
4
5
6
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.七种肿瘤标志物的最佳组合在非小细胞肺癌患者首次检查时对晚期阶段的预测作用
Anticancer Res. 2001 Jul-Aug;21(4B):3085-92.
7
[Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].癌胚抗原（CEA）、组织多肽抗原（TPA）、烯醇化酶（NSE）和胸苷激酶（TK）在肺癌原发性监测及预后中的应用价值
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):135-40.
8
9
Tissue polypeptide antigen in bronchogenic carcinoma.支气管癌中的组织多肽抗原
Neoplasma. 1993;40(5):301-3.
10
Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.神经元特异性烯醇化酶和组织多肽抗原在肺癌患者管理中的临床价值。
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):141-5.
引用本文的文献
1
Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib.吉非替尼治疗的非小细胞肺癌患者可溶性白细胞介素-2受体水平升高。
J Cancer Res Clin Oncol. 2006 Nov;132(11):719-25. doi: 10.1007/s00432-006-0120-x. Epub 2006 Jul 12.
Zotero 插件